UNICYCIVE THERAPEUTICS, INC. Preferred Stock, Dividend Rate, Percentage
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Preferred Stock, Dividend Rate, Percentage of 8.00% for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2025-05-14
- UNICYCIVE THERAPEUTICS, INC. preferred stock, dividend rate, percentage for the quarter ending 2025-03-31 was 8.00%, a 42.86% decline year-over-year.
- UNICYCIVE THERAPEUTICS, INC. preferred stock, dividend rate, percentage for the quarter ending 2024-03-31 was 14.00%, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. preferred stock, dividend rate, percentage for the quarter ending 2023-03-31 was 14.00%.
- UNICYCIVE THERAPEUTICS, INC. preferred stock, dividend rate, percentage for fiscal 2024 was 8.00%, a 42.86% decline from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. preferred stock, dividend rate, percentage for fiscal 2023 was 14.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 3 month | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|---|
| 2025-03-31 | 8.00% 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 8.00% 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 8.00% 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | 14.00% 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | 14.00% 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | 14.00% 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 14.00% 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | 14.00% 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 14.00% 10-Q · filed 2023-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |